Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Less immune activation following social stress in rural vs. urban participants raised with regular or no animal contact, respectively.

Böbel TS, Hackl SB, Langgartner D, Jarczok MN, Rohleder N, Rook GA, Lowry CA, Gündel H, Waller C, Reber SO.

Proc Natl Acad Sci U S A. 2018 May 15;115(20):5259-5264. doi: 10.1073/pnas.1719866115. Epub 2018 Apr 30.

2.

A pharmacokinetics and pharmacodynamics equivalence trial of the proposed pegfilgrastim biosimilar, MYL-1401H, versus reference pegfilgrastim.

Waller CF, Tiessen RG, Lawrence TE, Shaw A, Liu MS, Sharma R, Baczkowski M, Kothekar MA, Micales CE, Barve A, Ranganna GM, Pennella EJ.

J Cancer Res Clin Oncol. 2018 Jun;144(6):1087-1095. doi: 10.1007/s00432-018-2643-3. Epub 2018 Apr 18.

PMID:
29671069
3.

Child Maltreatment Is Associated with a Reduction of the Oxytocin Receptor in Peripheral Blood Mononuclear Cells.

Krause S, Boeck C, Gumpp AM, Rottler E, Schury K, Karabatsiakis A, Buchheim A, Gündel H, Kolassa IT, Waller C.

Front Psychol. 2018 Feb 27;9:173. doi: 10.3389/fpsyg.2018.00173. eCollection 2018.

4.

Effect of ABCG2, OCT1, and ABCB1 (MDR1) Gene Expression on Treatment-Free Remission in a EURO-SKI Subtrial.

Rinaldetti S, Pfirrmann M, Manz K, Guilhot J, Dietz C, Panagiotidis P, Spiess B, Seifarth W, Fabarius A, Müller M, Pagoni M, Dimou M, Dengler J, Waller CF, Brümmendorf TH, Herbst R, Burchert A, Janβen C, Goebeler ME, Jost PJ, Hanzel S, Schafhausen P, Prange-Krex G, Illmer T, Janzen V, Klausmann M, Eckert R, Büschel G, Kiani A, Hofmann WK, Mahon FX, Saussele S.

Clin Lymphoma Myeloma Leuk. 2018 Apr;18(4):266-271. doi: 10.1016/j.clml.2018.02.004. Epub 2018 Feb 8.

5.

Sustainability in Health care by Allocating Resources Effectively (SHARE) 8: developing, implementing and evaluating an evidence dissemination service in a local healthcare setting.

Harris C, Garrubba M, Melder A, Voutier C, Waller C, King R, Ramsey W.

BMC Health Serv Res. 2018 Mar 2;18(1):151. doi: 10.1186/s12913-018-2932-1.

6.

Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV.

Saussele S, Hehlmann R, Fabarius A, Jeromin S, Proetel U, Rinaldetti S, Kohlbrenner K, Einsele H, Falge C, Kanz L, Neubauer A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Oppliger Leibundgut E, Heim D, Krause SW, Hofmann WK, Hasford J, Pfirrmann M, Müller MC, Hochhaus A, Lauseker M.

Leukemia. 2018 May;32(5):1222-1228. doi: 10.1038/s41375-018-0055-7. Epub 2018 Feb 26.

7.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Schütz C, Inselmann S, Saussele S, Dietz CT, Müller MC, Eigendorff E, Brendel CA, Metzelder SK, Brümmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Mahon FX, Pfirrmann M, Burchert A.

Leukemia. 2018 Apr;32(4):1054. doi: 10.1038/leu.2017.348. Epub 2018 Jan 30.

PMID:
29381150
8.

An Unusual Subcutaneous Mass in an Otherwise Healthy Patient: A Case Report of Localized Histoplasmosis Diagnosed on Excisional Biopsy.

Esquibel BM, Waller CJ, Agger WA.

Case Rep Infect Dis. 2017;2017:9485793. doi: 10.1155/2017/9485793. Epub 2017 Oct 4.

9.

Immigrant with stomach pain, distension, nausea, and fever · Dx?

Tessier J, Waller C.

J Fam Pract. 2017 Sep;66(9):507-509.

PMID:
28863202
10.

Erratum to: Sustainability in Health care by Allocating Resources Effectively (SHARE) 5: developing a model for evidence-driven resource allocation in a local healthcare setting.

Harris C, Allen K, Waller C, Green S, King R, Ramsey W, Kelly C, Thiagarajan M.

BMC Health Serv Res. 2017 Aug 30;17(1):616. doi: 10.1186/s12913-017-2443-5. No abstract available.

11.

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Hehlmann R, Lauseker M, Saußele S, Pfirrmann M, Krause S, Kolb HJ, Neubauer A, Hossfeld DK, Nerl C, Gratwohl A, Baerlocher GM, Heim D, Brümmendorf TH, Fabarius A, Haferlach C, Schlegelberger B, Müller MC, Jeromin S, Proetel U, Kohlbrenner K, Voskanyan A, Rinaldetti S, Seifarth W, Spieß B, Balleisen L, Goebeler MC, Hänel M, Ho A, Dengler J, Falge C, Kanz L, Kremers S, Burchert A, Kneba M, Stegelmann F, Köhne CA, Lindemann HW, Waller CF, Pfreundschuh M, Spiekermann K, Berdel WE, Müller L, Edinger M, Mayer J, Beelen DW, Bentz M, Link H, Hertenstein B, Fuchs R, Wernli M, Schlegel F, Schlag R, de Wit M, Trümper L, Hebart H, Hahn M, Thomalla J, Scheid C, Schafhausen P, Verbeek W, Eckart MJ, Gassmann W, Pezzutto A, Schenk M, Brossart P, Geer T, Bildat S, Schäfer E, Hochhaus A, Hasford J.

Leukemia. 2017 Nov;31(11):2398-2406. doi: 10.1038/leu.2017.253. Epub 2017 Aug 14.

12.

History of child maltreatment and telomere length in immune cell subsets: Associations with stress- and attachment-related hormones.

Boeck C, Krause S, Karabatsiakis A, Schury K, Gündel H, Waller C, Kolassa IT.

Dev Psychopathol. 2018 May;30(2):539-551. doi: 10.1017/S0954579417001055. Epub 2017 Aug 14.

PMID:
28803568
13.

Data to Decisions: Creating a Culture of Model-Driven Drug Discovery.

Brown FK, Kopti F, Chang CZ, Johnson SA, Glick M, Waller CL.

AAPS J. 2017 Sep;19(5):1255-1263. doi: 10.1208/s12248-017-0124-2. Epub 2017 Aug 2.

PMID:
28770387
14.

Symptom and Quality of Life Improvement in LUX-Lung 8, an Open-Label Phase III Study of Second-Line Afatinib Versus Erlotinib in Patients With Advanced Squamous Cell Carcinoma of the Lung After First-Line Platinum-Based Chemotherapy.

Felip E, Hirsh V, Popat S, Cobo M, Fülöp A, Dayen C, Trigo JM, Gregg R, Waller CF, Soria JC, Goss GD, Gordon J, Wang B, Palmer M, Ehrnrooth E, Gadgeel SM.

Clin Lung Cancer. 2018 Jan;19(1):74-83.e11. doi: 10.1016/j.cllc.2017.06.002. Epub 2017 Jun 23.

15.

Contemporary management of subclavian and axillary artery injuries-A Western Trauma Association multicenter review.

Waller CJ, Cogbill TH, Kallies KJ, Ramirez LD, Cardenas JM, Todd SR, Chapman KJ, Beckman MA, Sperry JL, Anto VP, Eriksson EA, Leon SM, Anand RJ, Pearlstein M, Capano-Wehrle L, Cothren Burlew C, Fox CJ, Cullinane DC, Roberts JC, Harrison PB, Berg GM, Haan JM, Lightwine K.

J Trauma Acute Care Surg. 2017 Dec;83(6):1023-1031. doi: 10.1097/TA.0000000000001645.

PMID:
28715360
16.

Implementation and sex-specific analysis of students' attitudes toward a longitudinal, gender-specific medical curriculum - a pilot study.

Böckers A, Grab C, Waller C, Schulze U, Gerhardt-Szep S, Mayer B, Böckers TM, Öchsner W.

Educ Health (Abingdon). 2017 Jan-Apr;30(1):50-59. doi: 10.4103/efh.EfH_338_15.

17.

Sustainability in Health care by Allocating Resources Effectively (SHARE) 7: supporting staff in evidence-based decision-making, implementation and evaluation in a local healthcare setting.

Harris C, Allen K, Waller C, Dyer T, Brooke V, Garrubba M, Melder A, Voutier C, Gust A, Farjou D.

BMC Health Serv Res. 2017 Jun 21;17(1):430. doi: 10.1186/s12913-017-2388-8.

18.

Replacing PAPS: In vitro phase II sulfation of steroids with the liver S9 fraction employing ATP and sodium sulfate.

Weththasinghe SA, Waller CC, Fam HL, Stevenson BJ, Cawley AT, McLeod MD.

Drug Test Anal. 2018 Feb;10(2):330-339. doi: 10.1002/dta.2224. Epub 2017 Jul 18.

PMID:
28635171
19.

Sustainability in Health care by Allocating Resources Effectively (SHARE) 6: investigating methods to identify, prioritise, implement and evaluate disinvestment projects in a local healthcare setting.

Harris C, Allen K, Brooke V, Dyer T, Waller C, King R, Ramsey W, Mortimer D.

BMC Health Serv Res. 2017 May 25;17(1):370. doi: 10.1186/s12913-017-2269-1.

20.

Sustainability in Health care by Allocating Resources Effectively (SHARE) 5: developing a model for evidence-driven resource allocation in a local healthcare setting.

Harris C, Allen K, Waller C, Green S, King R, Ramsey W, Kelly C, Thiagarajan M.

BMC Health Serv Res. 2017 May 10;17(1):342. doi: 10.1186/s12913-017-2208-1. Erratum in: BMC Health Serv Res. 2017 Aug 30;17 (1):616.

21.
22.
23.

Microplastics in the Antarctic marine system: An emerging area of research.

Waller CL, Griffiths HJ, Waluda CM, Thorpe SE, Loaiza I, Moreno B, Pacherres CO, Hughes KA.

Sci Total Environ. 2017 Nov 15;598:220-227. doi: 10.1016/j.scitotenv.2017.03.283. Epub 2017 Apr 22. Review.

24.

Shared Consensus Machine Learning Models for Predicting Blood Stage Malaria Inhibition.

Verras A, Waller CL, Gedeck P, Green DV, Kogej T, Raichurkar A, Panda M, Shelat AA, Clark J, Guy RK, Papadatos G, Burrows J.

J Chem Inf Model. 2017 Mar 27;57(3):445-453. doi: 10.1021/acs.jcim.6b00572. Epub 2017 Mar 17.

PMID:
28257198
25.

[Prostate cancer units – hubs in the future care of men with prostate cancer].

Bratt O, Ahlgren G, Börjedahl AC, Franck-Lissbrant I, Waller C.

Lakartidningen. 2017 Jan 31;114. pii: D77U. Review. Swedish.

26.

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.

Schütz C, Inselmann S, Sausslele S, Dietz CT, Mu Ller MC, Eigendorff E, Brendel CA, Metzelder SK, Bru Mmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Xavier Mahon F, Pfirrmann M, Burchert A.

Leukemia. 2017 Apr;31(4):829-836. doi: 10.1038/leu.2017.9. Epub 2017 Jan 11. Erratum in: Leukemia. 2018 Jan 30;:.

PMID:
28074067
27.

Effects of the Adult Attachment Projective Picture System on Oxytocin and Cortisol Blood Levels in Mothers.

Krause S, Pokorny D, Schury K, Doyen-Waldecker C, Hulbert AL, Karabatsiakis A, Kolassa IT, Gündel H, Waller C, Buchheim A.

Front Hum Neurosci. 2016 Dec 8;10:627. doi: 10.3389/fnhum.2016.00627. eCollection 2016.

28.

Constant Ion Loss Method for the Untargeted Detection of Bis-sulfate Metabolites.

McLeod MD, Waller CC, Esquivel A, Balcells G, Ventura R, Segura J, Pozo ÓJ.

Anal Chem. 2017 Feb 7;89(3):1602-1609. doi: 10.1021/acs.analchem.6b03671. Epub 2017 Jan 9.

PMID:
27982580
29.

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.

Rugo HS, Barve A, Waller CF, Hernandez-Bronchud M, Herson J, Yuan J, Sharma R, Baczkowski M, Kothekar M, Loganathan S, Manikhas A, Bondarenko I, Mukhametshina G, Nemsadze G, Parra JD, Abesamis-Tiambeng ML, Baramidze K, Akewanlop C, Vynnychenko I, Sriuranpong V, Mamillapalli G, Ray S, Yanez Ruiz EP, Pennella E; Heritage Study Investigators.

JAMA. 2017 Jan 3;317(1):37-47. doi: 10.1001/jama.2016.18305.

PMID:
27918780
30.

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Schlenk RF, Stegelmann F, Reiter A, Jost E, Gattermann N, Hebart H, Waller C, Hochhaus A, Platzbecker U, Schafhausen P, Blau IW, Verbeek W, Heidel FH, Werner M, Kreipe H, Teleanu V, Benner A, Döhner H, Grießhammer M, Döhner K.

Leukemia. 2017 Apr;31(4):889-895. doi: 10.1038/leu.2016.299. Epub 2016 Oct 24.

PMID:
27774990
31.

Oxygen in the Heart: How Much is too Much?

Kalbitz M, Waller C, Huber-Lang M, Gebhard F, Thiemermann C, Radermacher P.

Shock. 2017 Apr;47(4):531-532. doi: 10.1097/SHK.0000000000000760. No abstract available.

PMID:
27749760
32.

A review of designer anabolic steroids in equine sports.

Waller CC, McLeod MD.

Drug Test Anal. 2017 Sep;9(9):1304-1319. doi: 10.1002/dta.2112. Epub 2016 Nov 18. Review.

PMID:
27732767
33.

[Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy].

Schuette W, Eberhardt WE, Waller C, Schirmacher P, Dietel M, Zirrgiebel U, Radke S, Thomas M.

Pneumologie. 2016 Sep;70(9):579-88. doi: 10.1055/s-0042-109760. Epub 2016 Sep 7. German.

PMID:
27603946
34.

High Prevalence of Insecure Attachment in Patients with Primary Hypertension.

Balint EM, Gander M, Pokorny D, Funk A, Waller C, Buchheim A.

Front Psychol. 2016 Aug 3;7:1087. doi: 10.3389/fpsyg.2016.01087. eCollection 2016.

35.

Inflammation in adult women with a history of child maltreatment: The involvement of mitochondrial alterations and oxidative stress.

Boeck C, Koenig AM, Schury K, Geiger ML, Karabatsiakis A, Wilker S, Waller C, Gündel H, Fegert JM, Calzia E, Kolassa IT.

Mitochondrion. 2016 Sep;30:197-207. doi: 10.1016/j.mito.2016.08.006. Epub 2016 Aug 13.

PMID:
27530300
36.

Detection and metabolic investigations of a novel designer steroid: 3-chloro-17α-methyl-5α-androstan-17β-ol.

Cawley AT, Blakey K, Waller CC, McLeod MD, Boyd S, Heather A, McGrath KC, Handelsman DJ, Willis AC.

Drug Test Anal. 2016 Jul;8(7):621-32. doi: 10.1002/dta.1832. Epub 2015 Jun 23.

PMID:
27443417
37.

Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial.

Al-Ali HK, Griesshammer M, le Coutre P, Waller CF, Liberati AM, Schafhausen P, Tavares R, Giraldo P, Foltz L, Raanani P, Gupta V, Tannir B, Ronco JP, Ghosh J, Martino B, Vannucchi AM.

Haematologica. 2016 Sep;101(9):1065-73. doi: 10.3324/haematol.2016.143677. Epub 2016 May 31.

38.

High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy.

Solari L, Krönig M, Ihorst G, Drognitz K, Heinz J, Jilg CA, Schultze-Seemann W, Engelhardt M, Waller CF.

Urol Int. 2016;96(4):399-405. doi: 10.1159/000445126. Epub 2016 Apr 14.

PMID:
27074038
39.

In vivo and in vitro metabolism of the designer anabolic steroid furazadrol in thoroughbred racehorses.

Waller CC, Cawley AT, Suann CJ, Ma P, McLeod MD.

J Pharm Biomed Anal. 2016 May 30;124:198-206. doi: 10.1016/j.jpba.2016.02.031. Epub 2016 Feb 26.

PMID:
26962720
40.

Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD.

Waller C, Bauersachs J, Hoppmann U, Höch J, Krause S, Szabo F, Engler H, Rottler E, Herrmann-Lingen C, Gündel H.

J Am Coll Cardiol. 2016 Mar 8;67(9):1124-6. doi: 10.1016/j.jacc.2015.12.031. No abstract available.

41.

High prevalence of posttraumatic stress in patients with primary hypertension.

Balint EM, Boseva P, Schury K, Guendel H, Rottbauer W, Waller C.

Gen Hosp Psychiatry. 2016 Jan-Feb;38:53-8. doi: 10.1016/j.genhosppsych.2015.10.002. Epub 2015 Oct 19.

PMID:
26596192
42.

Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

Fabarius A, Kalmanti L, Dietz CT, Lauseker M, Rinaldetti S, Haferlach C, Göhring G, Schlegelberger B, Jotterand M, Hanfstein B, Seifarth W, Hänel M, Köhne CH, Lindemann HW, Berdel WE, Staib P, Müller MC, Proetel U, Balleisen L, Goebeler ME, Dengler J, Falge C, Kanz L, Burchert A, Kneba M, Stegelmann F, Pfreundschuh M, Waller CF, Spiekermann K, Brümmendorf TH, Edinger M, Hofmann WK, Pfirrmann M, Hasford J, Krause S, Hochhaus A, Saußele S, Hehlmann R; SAKK and the German CML Study Group.

Ann Hematol. 2015 Dec;94(12):2015-24. doi: 10.1007/s00277-015-2494-9. Epub 2015 Sep 18.

PMID:
26385387
43.

Safety and Feasibility of a KineSpring Knee System for the Treatment of Osteoarthritis: A Case Series.

Hayes DA, Waller CS, Li CS, Vannabouathong C, Sprague S, Bhandari M.

Clin Med Insights Arthritis Musculoskelet Disord. 2015 Jul 29;8:47-54. doi: 10.4137/CMAMD.S24423. eCollection 2015.

44.

Attachment representation modulates oxytocin effects on the processing of own-child faces in fathers.

Waller C, Wittfoth M, Fritzsche K, Timm L, Wittfoth-Schardt D, Rottler E, Heinrichs M, Buchheim A, Kiefer M, Gündel H.

Psychoneuroendocrinology. 2015 Dec;62:27-35. doi: 10.1016/j.psyneuen.2015.07.003. Epub 2015 Jul 9.

PMID:
26221767
45.

Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO).

Vansteenkiste J, Barlesi F, Waller CF, Bennouna J, Gridelli C, Goekkurt E, Verhoeven D, Szczesna A, Feurer M, Milanowski J, Germonpre P, Lena H, Atanackovic D, Krzakowski M, Hicking C, Straub J, Picard M, Schuette W, O'Byrne K.

Ann Oncol. 2015 Aug;26(8):1734-40. doi: 10.1093/annonc/mdv219. Epub 2015 May 4.

PMID:
25939894
46.

Pseudomonas aeruginosa arylsulfatase: a purified enzyme for the mild hydrolysis of steroid sulfates.

Stevenson BJ, Waller CC, Ma P, Li K, Cawley AT, Ollis DL, McLeod MD.

Drug Test Anal. 2015 Oct;7(10):903-11. doi: 10.1002/dta.1782. Epub 2015 Mar 5.

PMID:
25739756
47.

[The wrong suspected diagnosis of a glomus jugulare tumor].

Jakob TF, Waller CF, Offergeld C.

Laryngorhinootologie. 2015 Jun;94(6):388-9. doi: 10.1055/s-0034-1396868. Epub 2015 Mar 4. German. No abstract available.

PMID:
25739069
48.

Fragment library design: using cheminformatics and expert chemists to fill gaps in existing fragment libraries.

Kutchukian PS, So SS, Fischer C, Waller CL.

Methods Mol Biol. 2015;1289:43-53. doi: 10.1007/978-1-4939-2486-8_5.

PMID:
25709032
49.

OPTN/SRTR 2013 Annual Data Report: heart.

Colvin-Adams M, Smith JM, Heubner BM, Skeans MA, Edwards LB, Waller CD, Callahan ER, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2015 Jan;15 Suppl 2:1-28. doi: 10.1111/ajt.13199.

50.

An open-label, multicenter, randomized phase Ib/II study of eribulin mesylate administered in combination with pemetrexed versus pemetrexed alone as second-line therapy in patients with advanced nonsquamous non-small-cell lung cancer.

Waller CF, Vynnychenko I, Bondarenko I, Shparyk Y, Hodge JP, Freeman A, Huber B, Lieberman R, Shelton MJ, Dave H.

Clin Lung Cancer. 2015 Mar;16(2):92-9. doi: 10.1016/j.cllc.2014.10.001. Epub 2014 Oct 15.

PMID:
25458558

Supplemental Content

Loading ...
Support Center